Synthorx

Provider of solutions for drug discovery, diagnostics, and vaccines using a synthetic DNA base pair

placeSan Diego, California, United States calendar_todayFounded 2014 groups50 employees language synthorx.com

Registered entities

Innovation

32 patent families (10 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 14,977 times.

YearFilings
20162
20171
20193
20206
202113
202219
202314
202412
202516
20264

Investor mix

7 investors on record; lead investors include RA Capital Management, Avalon Ventures, Correlation Ventures, Orbimed; 2 have since exited.

Investor typeCountShare
Venture capital686%
Other / undisclosed114%
Coming soon